Home » today » Health » will it be ready before the second wave of fall?

will it be ready before the second wave of fall?

The epidemic of Coronavirus continues to be in full swing all over the world. While some countries are still in the midst of the first wave, such as the United States or Brazil, in Europe today we fear a return to the situation experienced last spring. The recommendations are increasingly strict in a large number of countries around the world, and today we rely mainly on a future vaccine, to permanently stop the circulation of this deadly virus.

Nevertheless, today research does not know a good coordination between countries. The different states do indeed carry out their own tests, and it is difficult to imagine standardization on a global scale, for many years to come.

Nevertheless, research is advancing in many countries, but will we really be able to benefit from a vaccine this winter, or will we have to wait many more months before being able to become immunized against the? covid-19? Barbanews makes an update for you on this situation, and on this solution which could be saving for all.

Russia promises “millions of vaccines”

At present, Russia seems to be on the way to finding an effective vaccine, at least according to the authorities. The country has indeed promised millions of vaccines for the beginning of 2021. This thrills the WHO, which hopes that the protocols will be respected, so that the vaccines are tested as they should before. to be made available to patients.

Moderna vaccine in the USA

In the United States, a vaccine is also in preparation, by the company Moderna. This was named mRNA-1273. Its operation is a little different from a traditional vaccine, since it proposes to infect a fragment of the genetic code of covid-19, instead of opting for an inactivated virus. Like all vaccines, this would make it possible to generate an immune reaction, aimed at protecting the patient from the Coronavirus.

Tests for this vaccine have been carried out on monkeys, and it induces a good immune response. The virus does not appear to develop once inoculated, which is quite encouraging. These latest results date from the end of July.

Trials at the University of Oxford

Closer to home this time, a vaccine is currently being tested at the University of Oxford, in contribution with a Swedish firm, Astra Zeneca. This provides a good immune response as well, and more tests should be done. If these are conclusive, it is possible that this vaccine will be delivered by the end of the year.

And the French in all this?

For their part, have the French also launched testing protocols for a future vaccine? None of the trials have yet successfully passed phase 3 testing. Sanofi is in particular still in research, as well as Valnena. For the moment, no date is proposed for a possible release of these future vaccines. We will therefore have to wait to benefit from a vaccine made in France, it is very likely that our British neighbors are a little ahead of their research.

While waiting to be able to benefit from an effective vaccine, caution is always in order: it is essential to apply barrier gestures, and to wear the mask so as to avoid as much as possible the spread of the virus. The epidemic is largely up to us, and our ability to be reasonable, before a definitive solution is found.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.